# Curaleaf

> Curaleaf grows, manufactures, distributes and sells cannabis through U.S. dispensaries, wholesale accounts and an international medical network. Its portfolio includes Curaleaf, Select, Grassroots, FIND, Dark Heart and Anthem. The business combines consumer brands with cultivation, processing, licensed retail and medical distribution infrastructure.

- **Founded:** 2010
- **Headquarters:** Stamford, United States
- **Founders:** Boris Jordan (Co-founder; Chairman and Chief Executive Officer), Joseph Lusardi (Co-founder; Executive Vice Chairman)
- **Products:** Curaleaf dispensaries, Select, Grassroots, FIND, Dark Heart and Anthem
- **Notable:** Built an integrated U.S. retail, wholesale, cultivation and manufacturing platform., Entered European medical cannabis through the EMMAC acquisition completed in April 2021., FY2025 international revenue rose 63% to approximately US$172.5 million.

## Products & services

- **Curaleaf dispensaries** — Licensed medical and adult-use cannabis retail; menus and eligibility vary by jurisdiction.
- **Select** — Cannabis oil and vape brand; the October 2026 Florida assortment includes the Briq 2 all-in-one vape with ACE oil.
- **Grassroots** — Cannabis flower and concentrates brand in the company portfolio.
- **FIND** — Cannabis flower brand offered in Curaleaf retail assortments.
- **Dark Heart and Anthem** — Portfolio brands including Dark Heart flower and Anthem pre-rolls in the October 2026 Florida assortment.
- **Curaleaf International** — Medical cannabis cultivation, processing, manufacturing and distribution across international markets.
- **Curaleaf Clinic and Pharmacy** — UK medical cannabis assessment, prescribing and pharmacy services subject to clinical eligibility.
- **B NOBLE partnership** — Cause-based pre-roll brand launched with Fab 5 Freddy and Bernard Noble; the launch pledged 10% of product proceeds to local social equity organizations.

## Achievements

- Built an integrated U.S. retail, wholesale, cultivation and manufacturing platform.
- Entered European medical cannabis through the EMMAC acquisition completed in April 2021.
- FY2025 international revenue rose 63% to approximately US$172.5 million.
- Q2 2026 net revenue rose 10% year over year to US$340.1 million.
- Developed a medical research program including the UK Medical Cannabis Registry.

## Latest updates

- **2026-10** — October 20 announcement said Port Orange would open October 21, bringing the U.S. retail footprint to 190 locations, including 80 in Florida.
- **2026-10** — On October 19, Curaleaf challenged Aurora’s rejection of its enhanced acquisition proposal; the transaction remained contested.
- **2026-10** — Curaleaf International announced free, localized healthcare professional education resources in Poland on October 8.
- **2026-08** — Reported Q2 revenue of US$340.1 million, US$51.4 million international revenue and approximately US$12.5 million consolidated net income; the income statement also showed a US$26.3 million pretax loss and US$38.8 million tax benefit.

## Links

- Website: https://curaleaf.com
- LinkedIn: https://www.linkedin.com/company/curaleaf
- Twitter/X: https://twitter.com/Curaleaf_Inc
- YouTube: https://www.youtube.com/channel/UCjD4LUBOWFUxXmysQ06NPsQ
- Instagram: https://www.instagram.com/curaleaf.usa/
- Facebook: https://www.facebook.com/CuraleafInc/

---

Profile page: https://yespress.io/curaleaf
Published by YesPress — https://yespress.io
Last updated: 2026-10-24